VCI Wealth Management LLC increased its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 46.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,547 shares of the company's stock after purchasing an additional 5,599 shares during the quarter. VCI Wealth Management LLC's holdings in Colgate-Palmolive were worth $1,595,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also added to or reduced their stakes in CL. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive during the 4th quarter valued at about $32,000. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive in the third quarter valued at approximately $42,000. Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $53,000. Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive in the third quarter worth approximately $64,000. Finally, True Wealth Design LLC increased its stake in shares of Colgate-Palmolive by 1,460.9% in the third quarter. True Wealth Design LLC now owns 718 shares of the company's stock worth $75,000 after buying an additional 672 shares during the period. 80.41% of the stock is owned by institutional investors.
Colgate-Palmolive Stock Down 1.4 %
Shares of CL traded down $1.29 during trading hours on Tuesday, hitting $89.92. The company had a trading volume of 4,790,714 shares, compared to its average volume of 5,159,712. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The firm has a fifty day moving average price of $91.74 and a 200-day moving average price of $97.40. The stock has a market capitalization of $73.47 billion, a price-to-earnings ratio of 25.77, a P/E/G ratio of 3.59 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's payout ratio is 57.31%.
Insider Activity at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.34% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on CL. StockNews.com lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Barclays cut their target price on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a research note on Friday, January 17th. TD Cowen lowered their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating on the stock in a research report on Thursday, January 16th. Finally, Stifel Nicolaus decreased their target price on Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating for the company in a report on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $101.11.
Check Out Our Latest Analysis on CL
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.